Pascal Lenain
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 7
- Oncology 12
- Viral-associated cancers and disorders 5
- Co-authors
- Thierry Façon (7 shared papers)Philippe Moreau (8 shared papers)Claire Mathiot (5 shared papers)Stéphane Leprêtre (18 shared papers)Philippe Casassus (4 shared papers)Lotfi Benboubker (4 shared papers)Aspasia Stamatoullas (14 shared papers)Cyrille Hulin (4 shared papers)
In The Last Decade
Pascal Lenain
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 73
- Hematology 839
- Genetics 301
- Oncology 560
- Pathology and Forensic Medicine 329
- Molecular Biology 565
Countries citing papers authored by Pascal Lenain
This map shows the geographic impact of Pascal Lenain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Lenain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Lenain more than expected).
Fields of papers citing papers by Pascal Lenain
This network shows the impact of papers produced by Pascal Lenain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Lenain. The network helps show where Pascal Lenain may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Lenain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 383 | |
| 2 | 2009 | 268 | |
| 3 | 2014 | 109 | |
| 4 | patients with the description of a new scoring system and its validation on 253 other patients. | 2000 | 99 |
| 5 | 2010 | 92 | |
| 6 | 2006 | 76 | |
| 7 | 2000 | 60 | |
| 8 | 2002 | 56 | |
| 9 | 2000 | 54 | |
| 10 | 2002 | 35 | |
| 11 | 2000 | 34 | |
| 12 | 2012 | 27 | |
| 13 | 2014 | 22 | |
| 14 | 2013 | 16 | |
| 15 | 2015 | 13 | |
| 16 | 2002 | 13 | |
| 17 | ¹⁸F-FDG-PET/CT Imaging in Patients with Febrile Neutropenia and Haematological Malignancies. | 2015 | 11 |
| 18 | 2000 | 10 | |
| 19 | 2015 | 8 | |
| 20 | 2018 | 8 |
About Pascal Lenain
Pascal Lenain is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Viral-associated cancers and disorders (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Antifungal resistance and susceptibility (3 papers) and Blood transfusion and management (3 papers). The work is most often cited by research in Hematology (839 citations), Genetics (301 citations), Oncology (560 citations), Pathology and Forensic Medicine (329 citations) and Molecular Biology (565 citations). Pascal Lenain has collaborated with scholars based in France, Belgium and Tunisia. Frequent co-authors include Thierry Façon, Philippe Moreau, Claire Mathiot, Stéphane Leprêtre, Philippe Casassus, Lotfi Benboubker, Aspasia Stamatoullas, Cyrille Hulin, Jean‐Luc Harousseau and Hervé Avet‐Loiseau. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Leukemia Research and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.